Fourrier-Réglat A - Search Results

1

Benzodiazepines and injurious falls in community dwelling elders.

Pariente A, Dartigues JF, Benichou J, Letenneur L, Moore N, Fourrier-Réglat A. Pariente A, et al. Drugs Aging. 2008;25(1):61-70. doi: 10.2165/00002512-200825010-00007. Drugs Aging. 2008. PMID: 18184030

2

Factors associated with serious adverse reactions to cholinesterase inhibitors: a study of spontaneous reporting.

Pariente A, Sanctussy DJ, Miremont-Salamé G, Moore N, Haramburu F, Fourrier-Réglat A; l'Association Française des Centres Régionaux de Pharmacovigilance (CRPV). Pariente A, et al. CNS Drugs. 2010 Jan;24(1):55-63. doi: 10.2165/11530300-000000000-00000. CNS Drugs. 2010. PMID: 20030419

3

Engagement in leisure activities and benzodiazepine use in a French community-dwelling elderly population.

Bazin F, Noize P, Dartigues JF, Ritchie KA, Tavernier B, Moore N, Pariente A, Fourrier-Reglat A. Bazin F, et al. Int J Geriatr Psychiatry. 2012 Jul;27(7):716-21. doi: 10.1002/gps.2773. Epub 2011 Aug 31. Int J Geriatr Psychiatry. 2012. PMID: 21882242

4

Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias.

Pariente A, Gregoire F, Fourrier-Reglat A, Haramburu F, Moore N. Pariente A, et al. Drug Saf. 2007;30(10):891-8. doi: 10.2165/00002018-200730100-00007. Drug Saf. 2007. PMID: 17867726

5

Prevalence of cholinesterase inhibitors in subjects with dementia in Europe.

Pariente A, Helmer C, Merliere Y, Moore N, Fourrier-Réglat A, Dartigues JF. Pariente A, et al. Pharmacoepidemiol Drug Saf. 2008 Jul;17(7):655-60. doi: 10.1002/pds.1613. Pharmacoepidemiol Drug Saf. 2008. PMID: 18508393

6

Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study.

Noize P, Bazin F, Dufouil C, Lechevallier-Michel N, Ancelin ML, Dartigues JF, Tzourio C, Moore N, Fourrier-Réglat A. Noize P, et al. Pharmacoepidemiol Drug Saf. 2009 Apr;18(4):310-9. doi: 10.1002/pds.1717. Pharmacoepidemiol Drug Saf. 2009. PMID: 19241438

7

Factors associated with persistence of cholinesterase inhibitor treatments in the elderly.

Pariente A, Pinet M, Moride Y, Merlière Y, Moore N, Fourrier-Réglat A. Pariente A, et al. Pharmacoepidemiol Drug Saf. 2010 Jul;19(7):680-6. doi: 10.1002/pds.1933. Pharmacoepidemiol Drug Saf. 2010. PMID: 20583209

8

A potential competition bias in the detection of safety signals from spontaneous reporting databases.

Pariente A, Didailler M, Avillach P, Miremont-Salamé G, Fourrier-Reglat A, Haramburu F, Moore N. Pariente A, et al. Pharmacoepidemiol Drug Saf. 2010 Nov;19(11):1166-71. doi: 10.1002/pds.2022. Pharmacoepidemiol Drug Saf. 2010. PMID: 20848561

9

Validity of chronic drug exposure presumed from repeated patient interviews varied according to drug class.

Noize P, Bazin F, Pariente A, Dufouil C, Ancelin ML, Helmer C, Moore N, Fourrier-Réglat A. Noize P, et al. J Clin Epidemiol. 2012 Oct;65(10):1061-8. doi: 10.1016/j.jclinepi.2012.04.009. Epub 2012 Jul 21. J Clin Epidemiol. 2012. PMID: 22819646

10

Use of benzodiazepines and z-drugs not compliant with guidelines and associated factors: a population-based study.

Panes A, Pariente A, Bénard-Laribière A, Lassalle R, Dureau-Pournin C, Lorrain S, Tournier M, Fourrier-Réglat A. Panes A, et al. Eur Arch Psychiatry Clin Neurosci. 2020 Feb;270(1):3-10. doi: 10.1007/s00406-018-0966-3. Epub 2018 Dec 11. Eur Arch Psychiatry Clin Neurosci. 2020. PMID: 30539229

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters